Intervention Review

Ticlopidine versus oral anticoagulation for coronary stenting

  1. Benilde Cosmi1,*,
  2. Andrea Rubboli2,
  3. Cristina C Castelvetri3,
  4. Milena Milandri4

Editorial Group: Cochrane Heart Group

Published Online: 23 OCT 2001

Assessed as up-to-date: 11 AUG 2001

DOI: 10.1002/14651858.CD002133


How to Cite

Cosmi B, Rubboli A, Castelvetri CC, Milandri M. Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Database of Systematic Reviews 2001, Issue 4. Art. No.: CD002133. DOI: 10.1002/14651858.CD002133.

Author Information

  1. 1

    S. Orsola-Malpighi University Hospital, Division of Angiology and Blood Coagulation M. Golinelli, Bologna, Italy

  2. 2

    Ospedale Maggiore C.A. Pizzardi, Department of Cardiology, Bologna, Italy

  3. 3

    University of Bologna, Department of Pharmacology, Bologna, Italy

  4. 4

    Ospedale Maggiore C.A. Pizzardi, Dipartimento Medico I, Bologna, Italy

*Benilde Cosmi, Division of Angiology and Blood Coagulation M. Golinelli, S. Orsola-Malpighi University Hospital, Via Albertoni 15, Bologna, 40138, Italy. benilde.cosmi@unibo.it.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 23 OCT 2001

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Lina Badimon, Guiomar Mendieta, Gemma Vilahur, Diferencias en los mecanismos de acción de los nuevos antiagregantes: ¿cómo actúan?, Revista Española de Cardiología Suplementos, 2014, 14, 3

    CrossRef

  2. 2
    Matthew P. Doogue, Evan J. Begg, Paul Bridgman, Clopidogrel Hypersensitivity Syndrome With Rash, Fever, and Neutropenia, Mayo Clinic Proceedings, 2005, 80, 10, 1368

    CrossRef

  3. 3
    Sanne Dorhout Mees, Walter M van den Bergh, Ale Algra, Gabriel JE Rinkel, Antiplatelet therapy for aneurysmal subarachnoid haemorrhage, The Cochrane Library,
  4. 4
    Fabiana Rollini, Francesco Franchi, Ana Muñiz-Lozano, Dominick J. Angiolillo, Ticlopidine,